Search Results - "Claxton, J'Neka"

Thirty-Year Survival after Cardiac Surgery for Patients with Turner Syndrome by Alam, Sabikha, Claxton, J'Neka S., Mortillo, Michael, Sassis, Leandros, Kefala-Karli, Pelagia, Silberbach, Michael, Kochilas, Lazaros, Wechsler, Stephanie Burns

“…To evaluate long-term survival in patients with Turner syndrome after congenital heart surgery with a focus on left heart obstructive lesions (LHOLs). We…”
Get full text

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation by Chen, Nemin, Alam, Aniqa B, Lutsey, Pamela L, MacLehose, Richard F, Claxton, J'Neka S, Chen, Lin Y, Chamberlain, Alanna M, Alonso, Alvaro

“…Background Polypharmacy is highly prevalent in elderly people with chronic conditions, including atrial fibrillation (AF). The impact of polypharmacy on…”
Get full text

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation by Chen, Nemin, Lutsey, Pamela L, MacLehose, Richard F, Claxton, J'Neka S, Norby, Faye L, Chamberlain, Alanna M, Bengtson, Lindsay G S, O'Neal, Wesley T, Chen, Lin Y, Alonso, Alvaro

“…Background Oral anticoagulants ( OACs ) in patients with atrial fibrillation ( AF ), in addition to reducing stroke risk, could also prevent adverse cognitive…”
Get full text

Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation by Claxton, J'Neka S., Chamberlain, Alanna M., Lutsey, Pamela L., Chen, Lin Y., MacLehose, Richard F., Bengtson, Lindsay G.S., Alonso, Alvaro

“…The burden imposed by multimorbidity on outcomes and on the effectiveness of atrial fibrillation therapies in elderly adults with atrial fibrillation is…”
Get full text

Trends in mortality risk of patients with congenital heart disease during the COVID-19 pandemic by Yang, Yanxu, Kuo, Kristina, Claxton, J'Neka S, Knight, Jessica H, Huang, Yijian, Oster, Matthew E, Kochilas, Lazaros K

“…Cardiovascular conditions are considered risk factors for poor outcomes associated with COVID-19. However, the effect of the COVID-19 pandemic on the mortality…”
Get full text

Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation by O'Neal, Wesley T., Sandesara, Pratik B., Claxton, J'Neka S., MacLehose, Richard F., Chen, Lin Y., Bengtson, Lindsay G.S., Chamberlain, Alanna M., Norby, Faye L., Lutsey, Pamela L., Alonso, Alvaro

“…Early cardiology involvement after atrial fibrillation (AF) diagnosis is associated with increased oral anticoagulant prescription fills and reduced stroke…”
Get full text

A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants by Claxton, J'Neka S., MacLehose, Richard F., Lutsey, Pamela L., Norby, Faye L., Chen, Lin Y., O'Neal, Wesley T., Chamberlain, Alanna M., Bengtson, Lindsay G.S., Alonso, Alvaro

“…Stroke risk stratification scores (eg, CHA2DS2-VASc) are used to tailor therapeutic recommendations for patients with atrial fibrillation (AF) in different…”
Get full text

Geographic Disparities in the Incidence of Stroke among Patients with Atrial Fibrillation in the United States by Claxton, J'Neka S., Lutsey, Pamela L., MacLehose, Richard F., Chen, Lin Y., Lewis, Tené T., Alonso, Alvaro

“…Aim: To determine whether regional variation in stroke incidence exists among individuals with AF. Methods: Using healthcare utilization claims from 2 large US…”
Get full text

Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience by Oster, Matthew E., Yang, Yanxu, Shi, Caroline, Anderson, Susan, Knight, Jessica, Spector, Logan G., Aldoss, Osamah, Canter, Charles E., Gaitonde, Mansi, Hiremath, Gurumurthy, John, Anitha, Kozik, Deborah J., Marino, Bradley S., McHugh, Kimberly E., Overman, David, Raghuveer, Geetha, Louis, James, Jacobs, Jeffrey P., Gurvitz, Michelle, Smith, Grace, Claxton, J'Neka S., Kuo, Kristina, Flores, Jessica M., Velani, Romie N., Thomas, Amanda, Mertens, Ann, Basler, Mason, Carey, Violet, Gavalas, Charlotte, Johnson, Madison, Mathews, Anita, Nelson, Jennifer, O'Grady, Katrin, Riley, Emily, Roesler, Michelle, Sykes, Amber, Young, Daniel, Kochilas, Lazaros K.

“…With improved survival of adults with congenital heart disease (CHD) comes a need to understand the lifelong outcomes of this population. The aim of this paper…”
Get full text

Endogenous carbamylation of renal medullary proteins by Claxton, J'Neka S, Sandoval, Pablo C, Liu, Gary, Chou, Chung-Lin, Hoffert, Jason D, Knepper, Mark A

“…Protein carbamylation is a post-translational modification that can occur in the presence of urea. In solution, urea is in equilibrium with ammonium cyanate,…”
Get full text

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation by O'Neal, Wesley T., Sandesara, Pratik B., Claxton, J'Neka S., MacLehose, Richard F., Chen, Lin Y., Bengtson, Lindsay G. S., Chamberlain, Alanna M., Norby, Faye L., Lutsey, Pamela L., Alonso, Alvaro

“…Background Differences in anticoagulation rates and direct oral anticoagulant use by provider specialty may identify an area of practice improvement to reduce…”
Get full text

Long-term Outcomes After Surgical Intervention for Congenital Supravalvar Aortic Stenosis in Children by Zinyandu, Tawanda, Knight, Jessica H., Thomas, Amanda S., Claxton, J’Neka, Montero, Alejandro, Shaw, Fawwaz R., Kochilas, Lazaros K.

“…Primary supravalvar aortic stenosis (SVAS) is a rare congenital cardiovascular condition that can coexist with Williams-Beuren syndrome, coronary artery…”
Get full text

Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer by O’Neal, Wesley T., Claxton, J’Neka S., Sandesara, Pratik B., MacLehose, Richard F., Chen, Lin Y., Bengtson, Lindsay G.S., Chamberlain, Alanna M., Norby, Faye L., Lutsey, Pamela L., Alonso, Alvaro

“…It is unknown whether early cardiology involvement shortly after atrial fibrillation (AF) diagnosis is associated with favorable outcomes in AF patients who…”
Get full text

Systems-level identification of PKA-dependent signaling in epithelial cells by Isobe, Kiyoshi, Jung, Hyun Jun, Yang, Chin-Rang, Claxton, J’Neka, Sandoval, Pablo, Burg, Maurice B., Raghuram, Viswanathan, Knepper, Mark A.

“…G protein stimulatory α-subunit (Gαs)-coupled heptahelical receptors regulate cell processes largely through activation of protein kinase A (PKA). To identify…”
Get full text

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants by Claxton, J'Neka S, MacLehose, Richard F, Lutsey, Pamela L, Norby, Faye L, Chen, Lin Y, O'Neal, Wesley T, Chamberlain, Alanna M, Bengtson, Lindsay G S, Alonso, Alvaro

“…No scores presently exist to predict bleeding in atrial fibrillation (AF) populations using direct oral anticoagulants (DOACs). We used data from two…”
Get full text

Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism by Lutsey, Pamela L, MacLehose, Richard F, Claxton, J’Neka S, Walker, Rob F, Adam, Terrence J, Alonso, Alvaro, Zakai, Neil A

“…Little is known about the impact of oral anticoagulation (OAC) choice on healthcare encounters during venous thromboembolism (VTE) primary treatment. Among…”
Get full text

Associations of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation: The Atherosclerosis Risk in Communities Study by Garg, Parveen K, Claxton, J'Neka S, Soliman, Elsayed Z, Chen, Lin Y, Lewis, Tené T, Mosley, Thomas, Alonso, Alvaro

“…We examined the relationships of anger, vital exhaustion, anti-depressant use, and poor social ties with incident atrial fibrillation in a biracial cohort of…”
Get full text

Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database by Subramanya, Vinita, Claxton, J'Neka S, Lutsey, Pamela L, MacLehose, Richard F, Chen, Lin Y, Chamberlain, Alanna M, Norby, Faye L, Alonso, Alvaro

“…Women with atrial fibrillation (AF) experience greater symptomatology, worse quality of life, and have a higher risk of stroke as compared to men, but are less…”
Get full text

Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation by O'Neal, Wesley T, Alam, Aniqa B, Sandesara, Pratik B, Claxton, J'Neka S, MacLehose, Richard F, Chen, Lin Y, Bengtson, Lindsay G S, Chamberlain, Alanna M, Norby, Faye L, Lutsey, Pamela L, Alonso, Alvaro

“…Outcomes among atrial fibrillation (AF) patients may differ according to race/ethnicity and sex due to differences in biology, the prevalence of cardiovascular…”
Get full text

Systems-level analysis reveals selective regulation of Aqp2 gene expression by vasopressin by Sandoval, Pablo C., Claxton, J’Neka S., Lee, Jae Wook, Saeed, Fahad, Hoffert, Jason D., Knepper, Mark A.

“…Vasopressin-mediated regulation of renal water excretion is defective in a variety of water balance disorders in humans. It occurs in part through long-term…”
Get full text